4.6 Review

Margins in breast conserving surgery: A practice-changing process

Journal

EJSO
Volume 42, Issue 5, Pages 631-640

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.ejso.2016.01.019

Keywords

Margins; Breast conserving surgery; Breast cancer

Ask authors/readers for more resources

Margins in breast conserving surgery (BCS) have been a long standing subject debate: This largely arises from the absence of a consensus on what constitutes an adequate margin width, resulting in re-excision rates of 25-40% for close or positive margins and its consequent impact upon cosmesis, economic costs, patient dissatisfaction and lack of bearing on survival. Accepting that the increased risk of local recurrences (LR) has its influence on survival, the decrease in LR in BCS in the last decade have been motivated by better surgical techniques for assessing negative margins, use of targeted therapies and in general with the multimodal treatment in the management of breast cancer patients. Since the publication of the consensus guidelines on margins there has evolved a trend of changing attitudes towards re-excision. Surgeons are considering margins in the context of all factors including not only patient and tumor characteristics but also the regional and systemic treatment the patient is receiving. (C) 2016 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants

M. J. Cardoso, L. Wyld, I. T. Rubio, M. Leidenius, G. Curigliano, B. Cutuli, L. Marotti, L. Biganzoli

BREAST (2019)

Article Oncology

Learning curves in intraoperative ultrasound guided surgery in breast cancer based on complete breast cancer excision and no need for second surgeries

Antonio Esgueva, Roberto Rodriguez-Revuelto, Martin Espinosa-Bravo, Juan Pablo Salazar, Isabel T. Rubio

Editorial Material Oncology

Missed opportunities and challenges for surgical breast cancer research in the era of personalized cancer treatment

Isabel T. Rubio, Michalis Kontos, M. T. F. D. Vrancken-Peeters, Roman Rouzier, Anita R. Skandarajah, Viviana Galimberti, Niels Kroman, Carmela Caballero, Shinji Ohno

Article Oncology

The requirements of a specialist breast centre

Laura Biganzoli, Fatima Cardoso, Marc Beishon, David Cameron, Luigi Cataliotti, Charlotte E. Coles, Roberto C. Delgado Bolton, Maria Die Trill, Sema Erdem, Maria Fjell, Romain Geiss, Mathijs Goossens, Christiane Kuhl, Lorenza Marotti, Peter Naredi, Simon Oberst, Jean Palussiere, Antonio Ponti, Marco Rosselli Del Turco, Isabel T. Rubio, Anna Sapino, Elzbieta Senkus-Konefka, Arko Skelin, Berta Sousa, Tiina Saarto, Alberto Costa, Philip Poortmans

BREAST (2020)

Review Obstetrics & Gynecology

Breast and axillary surgery in malignant breast disease: a review focused on literature of 2018 and 2019

Nina Ditsch, Isabel T. Rubio, Maria L. Gasparri, Jana de Boniface, Thorsten Kuehn

CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2020)

Article Oncology

Theoretical and practical knowledge curriculum for European Breast Surgeons

Tibor Kovacs, Isabel T. Rubio, Christos Markopoulos, Riccardo A. Audisio, Susan Knox, Thorsten Kuehn, Robert Mansel, Zoltan Matrai, Francesco Meani, Maurizio Nava, Lynda Wyld

Article Oncology

Standard Anthracycline Based Versus Docetaxel-Capecitabine in Early High Clinical and/or Genomic Risk Breast Cancer in the EORTC 10041/BIG 3-04 MINDACT Phase III Trial

Suzette Delaloge, Martine Piccart, Emiel Rutgers, Saskia Litiere, Laura J. van't Veer, Franchette van den Berkmortel, Etienne Brain, Aleksandra Dudek-Peric, Miguel Gil-Gil, Patricia Gomez, Florentine S. Hilbers, Zaman Khalil, Susan Knox, Sherko Kuemmel, Georg Kunz, Anne Lesur, Jean-Yves Pierga, Peter Ravdin, Isabel T. Rubio, Mahasti Saghatchian, Tineke J. Smilde, Alastair M. Thompson, Giuseppe Viale, Gabriele Zoppoli, Peter Vuylsteke, Konstantinos Tryfonidis, Coralie Poncet, Jan Bogaerts, Fatima Cardoso

JOURNAL OF CLINICAL ONCOLOGY (2020)

Article Oncology

Leveraging the increased rates of pathologic complete response after neoadjuvant treatment in breast cancer to de-escalate surgical treatments

Antonio Esgueva, Christian Siso, Martin Espinosa-Bravo, Carolina Sobrido, Ignacio Miranda, Juan P. Salazar, Isabel T. Rubio

Summary: This study demonstrates that achieving a pathologic complete response is beneficial for breast conservative surgery and sentinel lymph node biopsy. In selected subgroups, avoiding any axillary surgery after neoadjuvant treatment may be feasible. In cN+ patients, any pathologic complete response is associated with improved survival.

JOURNAL OF SURGICAL ONCOLOGY (2021)

Article Oncology

Complete Loss of EPCAM Immunoexpression Identifies EPCAM Deletion Carriers in MSH2-Negative Colorectal Neoplasia

Miriam Cuatrecasas, Inigo Gorostiaga, Cristina Riera, Esteban Saperas, Gemma Llort, Irmgard Costa, Xavier Matias-Guiu, Cristina Carrato, Matilde Navarro, Marta Pineda, Nuria Duenas, Joan Brunet, Vicente Marco, Isabel Trias, Jose Ignacio Busteros, Gemma Mateu, Francesc Balaguer, Maria-Teresa Fernandez-Figueras, Manel Esteller, Eva Musulen

CANCERS (2020)

Article Immunology

Analysis of tumor infiltrating CD4+and CD8+CDR3 sequences reveals shared features putatively associated to the anti-tumor immune response

Andrea Aran, Gonzalo Lazaro, Vicente Marco, Elisa Molina, Ferran Abanco, Vicente Peg, Maria Gion, Laia Garrigos, Jose Perez-Garcia, Javier Cortes, Merce Marti

Summary: Tumor-infiltrating lymphocytes (TILs) have predictive and prognostic value in breast cancer. TCR differences between CD4+ and CD8+ TILs were observed, and a more restricted TCR repertoire with higher similarity was found in CD4+ TILs.

FRONTIERS IN IMMUNOLOGY (2023)

Meeting Abstract Oncology

MINDACT: Long-term results of the large prospective trial testing the 70-gene signature MammaPrint as guidance for adjuvant chemotherapy in breast cancer patients.

Fatima Cardoso, Laura van't Veer, Coralie Poncet, Josephine Lopes Cardozo, Suzette Delaloge, Jean-Yves Pierga, Peter Vuylsteke, Etienne Brain, Giuseppe Viale, Sherko Kuemmel, Isabel T. Rubio, Gabriele Zoppoli, Alastair Mark Thompson, Erika Matos, Khalil Zaman, Florentine Hilbers, Aleksandra Dudek-Peric, Bart Meulemans, Martine J. Piccart-Gebhart, Emiel J. Rutgers

JOURNAL OF CLINICAL ONCOLOGY (2020)

Article Oncology

Should breast reconstruction and breast oncoplastic procedures be performed during the coronavirus pandemic?

Raghavan Vidya, Isabel T. Rubio, Regis Resende Paulinelli, Alberto Rancati, Agnieszka Kolacinska-Voytkuv, Marzia Salgarello, Hilton Becker

ECANCERMEDICALSCIENCE (2020)

Meeting Abstract Oncology

The genomic landscape of male breast cancers using the oncomine comprehensive assay for actionable mutations

Jane Bayani, Coralie Poncet, Cheryl Crozier, Quang M. Trinh, Megan Hopkins, Aime Lambert Uwimana, Tammy Piper, Carrie Cunningham, Monika Sobol, Stefan Aebi, Kim Benstead, Oliver Bogler, Lissandra Dal Lago, Florentine Hilbers, Ingrid Hedenfalk, Larissa Korde, Barbro Linderholm, John Martens, Lavinia Middleton, Melissa Murray, Catherine Kelly, Cecilia Nilsson, Monika Nowaczyk, Stephanie Peeters, Aleks Andra Peric, Peggy Porter, Carolien Schroder, Isabel T. Rubio, Kathryn J. Ruddy, Christi van Asperen, Danielle van den Weyngaert, Carolien H. M. van Deurzen, Elise van Leeuwen-Stok, Joanna Vermeij, Eric Winer, Lincoln D. Stein, Sharon H. Giordano, Fatima Cardoso, John M. S. Bartlett

CANCER RESEARCH (2020)

Meeting Abstract Oncology

The Technique of Sentinel Lymph Node Biopsy After Neoadjuvant Treatment in Breast Cancer is Crucial to Reduce False-negative Results: The ILINA Trial

C. Siso, A. Esgueva, I. Miranda, C. Sobrido, J. Salazar, M. Espinosa-Bravo, I. T. Rubio

ANNALS OF SURGICAL ONCOLOGY (2020)

Meeting Abstract Oncology

Axillary Staging in the Setting of a Preoperative Diagnosis of Ductal Cancer In Situ (DCIS): Results of an International Expert Panel and a Critical Guideline Performance Using Frequentist and Bayesian Analysis

Andreas Karakatsanis, Theodoros Foukakis, Per Karlsson, Eleftherios Mamounas, Anees Chagpar, John Boyages, Isabel Rubio, Bjorn Naume, Davide Mauri, Elsken van der Wall, Chirag Shah, Ava Kwong, Priscilla McAuliffe, Oreste Gentilini, Michail Ignatiadis, Ellen Schlichting, Janez Zgajnar, Francesco Meani, Marios Konstantinos Tasoulis, Pat Whitworth, Walter Weber, Petros Charalampoudis, Bahadir Gulluoglu, Lida Pistioli, Tove Filtenborg Tvedskov, Marjut Leidenius, Bruce Mann, Arjen Witkamp, Lynda Wyld, Rosa di Micco, Christos Markopoulos, Antonios Valachis, Fredrik Warnberg

ANNALS OF SURGICAL ONCOLOGY (2020)

Article Oncology

Preoperative 6-minute walk distance is associated with postoperative complications in patients undergoing laparoscopic gastrointestinal cancer surgery

Yuchao Liu, Zijia Liu, Liangyan Zhang, Yuelun Zhang, Ningchen Zhang, Yue Han, Le Shen

Summary: This study found an association between preoperative 6-min walk distance and postoperative complications in patients undergoing laparoscopic gastrointestinal cancer surgery.
Review Oncology

Uterine transposition versus uterine ventrofixation before radiotherapy as a fertility sparing option in young women with pelvic malignancies: Systematic review of the literature and dose simulation

Matteo Pavone, Rosa Autorino, Nicolo Bizzarri, Giuditta Chilorio, Vincenzo Valentini, Giacomo Corrado, Gabriella Ferrandina, Gabriella Macchia, Maria Antonietta Gambacorta, Giovanni Scambia, Denis Querleu

Summary: Ovarian transposition is an established method for protecting the ovaries from radiation, while surgical procedures for protecting the uterus are still under investigation. This study conducted a systematic review of uterine displacement techniques and performed dose simulation to assess the radiation dose received by the uterus. The results showed that the transposition approach was the most protective.
Article Oncology

A pragmatic approach improves the clinical management of stage IV gastric cancer: Comparison between the Meta-Gastro results and the GIRCG's retrospective series

Silvia Ministrini, Maria Bencivenga, Federica Filippini, Gianni Mura, Carlo Milandri, Maria Antonietta Mazzei, Giulio Bagnacci, Mattia Berselli, Manlio Monti, Paolo Morgagni, Leonardo Solaini, Daniele Marrelli, Stefania Piccioni, Stefano De Pascale, Luigina Graziosi, Rossella Reddavid, Fausto Rosa, Claudio Belluco, Guido Tiberio

Summary: The Italian Research Group for Gastric Cancer developed a prospective database to evaluate the impact of a pragmatic attitude on the management of stage IV gastric cancer patients. The study found that different metastatic sites did not affect survival rates, but multiple metastatic sites were associated with worse survival. Patients who could undergo curative resection had better survival rates. A more accurate diagnostic workup and staging had a favorable impact on survival.
Article Oncology

Stentless florence robotic intracorporeal neobladder (FloRIN), a feasibility prospective randomized clinical trial

Luca Lambertini, Fabrizio Di Maida, Anna Cadenar, Samuele Nardoni, Antonio Andrea Grosso, Francesca Valastro, Pietro Spinelli, Riccardo Fantechi, Agostino Tuccio, Gianni Vittori, Andrea Mari, Lorenzo Masieri, Andrea Minervini

Summary: The aim of this study was to evaluate the functional outcomes of Florence intracorporeal neobladder (FloRIN) configuration technique performed with a stentless procedure. The results showed that the stentless procedure was associated with shorter console time and lower estimated blood loss compared to the stent group. There were no significant differences in terms of perioperative features and mid-term functional outcomes between the two groups.
Article Oncology

Neoadjuvant chemotherapy followed by surgery for HPV-associated tonsillar cancer: Does imaging reflect the pathological response?

Geun-Jeon Kim, Jooin Bang, Hyun-Il Shin, Sang-Yeon Kim, Dong -Il Sun

Summary: This study evaluated the outcome of tonsillar cancer managed with neoadjuvant chemotherapy followed by surgery. The results showed that neoadjuvant chemotherapy reduced tumor volume and pathological adverse features, significantly decreasing the need for adjuvant therapy. A greater reduction in tumor volume predicted a complete pathologic response. There was no significant difference in survival rates between the groups.
Article Oncology

Factors of oncological failure in two stage hepatectomy for colorectal liver metastases

Alexandra Nassar, Stylianos Tzedakis, Ugo Marchese, Gaanan Naveendran, Remy Sindayigaya, Martin Gaillard, Francois Cauchy, Mickael Lesurtel, Brice Gayet, Olivier Soubrane, David Fuks

Summary: This study identified recurrence between the two stages and a larger tumor size in the future liver remnant as critical factors contributing to the failure of two-stage hepatectomy for bilobar colorectal liver metastases. These findings have important clinical implications for the selection and evaluation of TSH surgery.
Letter Oncology

Pancreatic cancer care: Lighting the way with the torch of staging laparoscopy and advanced imaging

Michele Fiore, Gian Marco Petrianni, Gabriele D'Ercole, Pasquale Trecca, Sara Ramella

Review Oncology

Impact of thoracic duct resection during radical esophagectomy on oncological and survival outcomes: Systematic review

Harry Farrow, Oliver J. Pickering, James A. Gossage, Philip H. Pucher

Summary: The inclusion or exclusion of the thoracic duct in radical esophagectomy for esophageal cancer is a controversial issue. While removing the thoracic duct may increase lymph node yield, it may also lead to higher morbidity without any survival benefit.
Article Oncology

A novel tumor staging system incorporating cN status for stratifying early stage esophageal squamous cell carcinoma patients after trimodal therapy

Xiaokun Li, Siyuan Luan, Chi Zhang, Weili Kong, Xin Xiao, Haowen Zhang, Jianfeng Zhou, Yushang Yang, Yang Xu, Yong Qiang, Pinhao Fang, Yi Shen, Yong Yuan

Summary: This study proposes a new staging system based on ypTNM stage and cN status for early stage ESCC patients after nCRT. The new ypTNM-cN staging system demonstrates superior predictive ability and classification efficacy compared to the AJCC 8th ypTNM staging system. It provides new insights for accurately stratifying ypI stage ESCC patients.